4 min read
ASCO 2026: RAS Is No Longer Undruggable
For decades, oncologists and drug developers shared an undeniable truth: KRAS – one of the most commonly mutated genes...
We're delighted to announce that Rachel Page, Veristat’s Chief Commercial Officer, will be participating as a panelist in the Life Sciences Dreamin' Webinar Series.
Following the overwhelming success of the 2023 Life Sciences Dreamin' conference, which had a robust agenda and featured star-studded speakers and attendees, we are extending the conversation to dive deeper into the intersection of Salesforce.com and the Life Sciences.
This engaging session, titled "Mastering the Mundane," will take place on March 21, 2024, from 12:00 PM to 01:00 PM (EST). Rachel will be joining industry experts Dr. Steve Herne, Dr. Julianne Baron, and Wendy Cofran. The panel will be facilitated by Neysha Arcelay.
Join us for this insightful webinar where you will learn how the intersection of Salesforce.com with the Life Sciences industry will impact our future.
Register now using the link below to secure your spot!
You can arrange a meeting with our experts by completing the form on the right side of this page. Discover how we can assist you in progressing your upcoming clinical trial or regulatory submission towards a successful outcome or explore our wide range of capabilities.
Website: Mastering the Mundane
Do you want to speak with our experts? Fill out the form below.
4 min read
Jun 15, 2026 Veristat News
For decades, oncologists and drug developers shared an undeniable truth: KRAS – one of the most commonly mutated genes...
10 min read
Jun 12, 2026 Veristat Blog
This May 2026 regulatory update highlights multiple guidances issued by the FDA across cell and gene therapy, clinical...